Skip to main content
. 2021 Apr 7;13(8):1752. doi: 10.3390/cancers13081752

Table 3.

Key secondary outcomes: anxiety (STAI I and STAI II), depression (MADRS and BDI), and plasma redox status parameters (GSH and TBARS).

Outcome CG Group
Mean (SD)
(n = 29)
PMI Group
Mean (SD)
(n = 26)
F (p-Value)
STAI I
T0 43.4 (12.1) 41.8 (10.7) Time effect: 5.07 (0.01)
T1 39.9 (11.3) 41.7 (9.2) Group effect: 1.91 (0.173)
T2 41.9 (9.0) 33.0 (8.1) Interaction group × time: 7.87 (0.001)
STAI II
T0 42.3 (10.7) 41.0 (9.3) Time effect: 7.46 (0.001)
T1 40.4 (11.0) 39.3 (9.7) Group effect: 5.52 (0.023)
T2 41.6 (10.3) 29.4 (10.3) Interaction group × time: 7.71 (0.0012)
MADRS
T0 10.2 (8.2) 8.6 (5.7) Time effect: 5.39 (0.0074)
T1 7.4 (6.5) 6.4 (3.5) Group effect: 3.27 (0.076)
T2 8.1 (5.4) 4.5 (3.4) Interaction group × time: 2.07 (0.136)
BDI
T0 12.2 (10.7) 10.2 (6.6) Time effect: 3.39 (0.041)
T1 9.5 (6.4) 6.6 (5.5) Group effect: 4.93 (0.031)
T2 11.0 (5.8) 5.9 (6.9) Interaction group × time: 1.37 (0.263)
GSH (µM)
T0 3.6 (1.7) 4.0 (1.6) Time effect: 13.77 (<0.0001)
T1 4.6 (2.7) 4.8 (2.0) Group effect: 1.52 (0.223)
T2 4.8 (2.0) 6.0 (3.8) Interaction group × time: 0.62 (0.542)
TBARS (µM)
T0 1.9 (1.2) 2.2 (1.7) Time effect: 5.83 (0.005)
T1 1.8 (0.9) 1.5 (0.8) Group effect: 0.08 (0.782)
T2 1.4 (0.7) 1.2 (0.4) Interaction group × time: 0.94 (0.395)

GSH: glutathione; TBARS: thiobarbituric acid reactive substances. Abbreviations are as in Table 2.